BGNE
Closed
Beigene Ltd
226.71
+42.00 (+22.74%)
Last Update: 29 Jan 2025 17:30:00
Yesterday: 184.71
Day's Range: 224.61 - 228.865
Send
sign up or login to leave a comment!
When Written:
215.53
BeiGene Ltd is a biotechnology company that focuses on developing and commercializing innovative cancer drugs. The company was founded in 2010 in Beijing, China, and has since expanded globally with offices in the United States, Europe, and Asia. BeiGene's product portfolio includes several oncology drugs, including zanubrutinib (Brukinsa), tislelizumab (BGB-A317), and pamiparib (BGB-290). The company is also actively pursuing research and development in other therapeutic areas, such as autoimmune diseases and infectious diseases. BeiGene has partnerships and collaborations with various pharmaceutical companies and academic institutions. The company is listed on the NASDAQ stock exchange under the ticker symbol "BGNE."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








